A retrospective study of venous thromboembolism in acute leukemia patients treated at the university of texas MD anderson cancer center

Cancer Medicine

Volumn 4, Issue 1, 2015, Pages 27-35

  Vu, Khanh ^a   Luong, Nhiem V ^b   Hubbard, Julie ^c   Zalpour, Ali ^a   Faderl, Stefan ^a   Thomas, Deborah A ^a   Yang, Daisy ^a   Kantarjian, Hagop ^a   Kroll, Michael H ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c Annapolis Oncology Center   (United States)

Author keywords

Acute leukemia; Anticoagulation; Cancer; Thrombosis; Venous thromboembolism

Indexed keywords

ANTIANEMIC AGENT; HORMONE; LOW MOLECULAR WEIGHT HEPARIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CANCER CENTER; CANCER PATIENT; CENTRAL VENOUS CATHETER; FEMALE; FOLLOW UP; HUMAN; LOWER EXTREMITY DEEP VEIN THROMBOSIS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; THROMBOCYTE COUNT; THROMBOCYTOPENIA; UNITED STATES; UPPER EXTREMITY DEEP VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; COMPLICATION; INCIDENCE; LEUKEMIA, MYELOID, ACUTE; MIDDLE AGED; MORTALITY; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TEXAS; TIME FACTOR; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CANCER CARE FACILITIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; PLATELET COUNT; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TEXAS; TIME FACTORS; VENOUS THROMBOEMBOLISM; YOUNG ADULT;

EID: 85005847563     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.332     Document Type: Article

References (37)

1. White, R. H. 2003. The epidemiology of venous thromboembolism. Circulation. 107(Suppl. 1):14-18.
2. Streiff, M. B. 2009. Diagnosis and initial treatment of venous thromboembolism in patients with cancer. J. Clin. Oncol. 27:4889-4894.
3. Kessler, C. M. 2009. The link between cancer and venous thromboembolism: a review. Am. J. Clin. Oncol. 32(Suppl. 4):S3-S7.
4. Stein, P. D., A. Beemath, F. A. Meyers, F. Kayali, E. Skaf, and R. E. Olson . 2006. Pulmonary embolism as a cause of death in patients who died with cancer. Am. J. Med. 119:163-165.
5. Khorana, A. A., C. W. Francis, E. Culakova, N. M. Kuderer, G. H. Lyman . 2007. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J. Thromb. Haemost. 5:632-634.
6. Gross, J. S., R. R. Neufeld, L. S. Libow, I. Gerber, M. Rodstein . 1988. Autopsy study of the elderly institutionalized patient. Review of 234 autopsies. Arch. Intern. Med. 148:173-176.
7. Lyman, G. H., A. A. Khorana, N. M. Kuderer, A. Y. Lee, J. I. Arcelus, E. P. Balaban, et al. 2013. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J. Clin. Oncol. 31:2189-2204.
8. Black, P. H. 1980. Shedding from normal and cancer-cell surfaces. N. Engl. J. Med. 303:1415-1416.
9. Varki, A. 2004. Trousseau's syndrome: multiple definitions and multiple mechanisms. Blood 110:1723-1729.
10. Rickles, F. R., A. Falanga, P. Montesinos, M. A. Sanz, B. Brenner, T. Barbui . 2007. Bleeding and thrombosis in acute leukemia: what does the future of therapy look like? Thromb. Res. 120(Suppl. 2):S99-S106.
11. Chojnowski, K., E. Wawrzyniak, J. Trelinski, J. Niewiarowska, C. Cierniewski . 1999. Assessment of coagulation disorders in patients with acute leukemia before and after cytostatic treatment. Leuk. Lymphoma 36:77-84.
12. Wun, T., and R. H. White . 2009. Epidemiology of cancer-related venous thromboembolism. Best Pract. Res. Clin. Haematol. 22:9-23.
13. Falanga, A., and M. Marchetti . 2009. Venous thromboembolism in the hematologic malignancies. J. Clin. Oncol. 27:4848-4857.
14. Shelke, A. R., and A. A. Khorana . 2011. Cancer-associated thrombosis: an update. Drug Discov. Today Dis. Mech. 8:e39-e45.
15. De Stefano, V., F. Sora, E. Rossi, P. Chiusolo, L. Laurenti, L. Fianchi, et al. 2005. The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment. J. Thromb. Haemost. 3:1985-1992.
16. Levitan, N., A. Dowlati, S. C. Remick, H. I. Tahsildar, L. D. Sivinski, R. Beyth, et al. 1999. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using medicare claims data. Medicine 78:285-291.
17. Lee, A. Y. Y., and M. N. Levine . 2003. Venous thromboembolism and cancer: risks and outcomes. Circulation 107(Suppl. 1):I17-I21.
18. Ku, G. H., R. H. White, H. K. Chew, D. J. Harvey, H. Zhou, T. Wun . 2009. Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival. Blood 113:3911-3917.
19. Campigotto, F., D. Neuberg, and J. I. Zwicker . 2012. Accounting for death as a competing risk in cancer-associated thrombosis studies. Thromb. Res. 129(Suppl. 1):S85-S87.
20. Chew, H. K., T. Wun, D. Harvey, H. Zhou, R. H. White . 2006. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch. Intern. Med. 166:458-464.
21. Castelli, R., B. Ferrari, A. Cortelezzi, A Guariglia . 2010. Thromboembolic complications in malignant haematological disorders. Curr. Vasc. Pharmacol. 8:482-494.
22. Wun, T., and R. H. White . 2010. Venous thromboembolism in patients with acute leukemia, lymphoma, and multiple myeloma. Thromb. Res. 125(Suppl. 2):S96-S102.
23. Chong, B. H., and S.-H. Lee . 2007. Management of thromboembolism in hematologic malignancies. Semin. Thromb. Hemost. 33:435-448.
24. Falanga, A., and F. R. Rickles . 2007. Management of thrombohemorrhagic syndromes (THS) in hematologic malignancies. ASH Educ. Program Book 2007: 165-171.
25. Mohren, M., I. Markmann, K. Jentsch-Ullrich, M. Koenigsmann, G. Lutze, A. Franke . 2006. Increased risk of venous thromboembolism in patients with acute leukaemia. Br. J. Cancer 94:200-202.
26. Menell, J. S., G. M. Cesarman, A. T. Jacovina, M. A. McLaughlin, E. A. Lev, K. A. Hajjar . 1999. Annexin II and bleeding in acute promyelocytic leukemia. N. Engl. J. Med. 340:994-1004.
27. Choudry, A., and T. G. DeLoughery . 2012. Bleeding and thrombosis in acute promyleocytic leukemia. Am. J. Hematol. 87:596-603.
28. Ziegler, S., W. R. Sperr, P. Knobl, S. Lehr, A. Weltermann, U. Jager, et al. 2005. Symptomatic venous thromboembolism in acute leukemia. Incidence, risk factors, and impact on prognosis. Thromb. Res. 115:59-64.
29. Khorana, A. A., C. W. Francis, E. Culakova, R. I. Fisher, N. M. Kuderer, G. H. Lyman . 2006. Thromboembolism in hospitalized neutropenic cancer patients. J. Clin. Oncol. 24:484-490.
30. Kantarjian, H. M., S. O'Brien, T. L. Smith, J. Cortes, F. J. Giles, M. Beran, et al. 2000. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J. Clin. Oncol. 18:547-561.
31. Levine, M. N., M. Gent, J. Hirsh, A. Arnold, M. D. Goodyear, W. Hryniuk, et al. 1988. The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer. N. Engl. J. Med. 318:404-407.
32. Elliott, M. A., R. C. Wolf, C. C. Hook, R. K. Pruthi, J. A. Heit, L. L. Letendre, et al. 2004. Thromboembolism in adults with acute lymphoblastic leukemia during induction with L-asparaginase-containing multi-agent regimens: incidence, risk factors, and possible role of antithrombin. Leuk. Lymphoma 45:1545-1551.
33. Grace, R. F., S. E. Dahlberg, D. Neuberg, S. E. Sallan, J. M. Connors, E. J. Neufeld, et al. 2011. The frequency and management of Asparaginase-related thrombosis in pediatric and adult patients with acute lymphoblastic leukemia treated on Dana-Farber cancer institute consortium protocols. Br. J. Haematol. 152:452-459.
34. Baskin, J. L., C. H. Pui, U. Reiss, J. A. Wilimas, M. L. Metzger, R. C. Ribeiro, et al. 2009. Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet 374:159-169.
35. Shivakumar, S. P., D. R. Anderson, and S. Couban . 2009. Catheter-associated thrombosis in patients with malignancy. J. Clin. Oncol. 27:4858-4864.
36. Lee, A. Y., M. N. Levine, R. I. Baker, C. Bowden, A. K. Kakkar, M. Prins, et al. 2003. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N. Engl. J. Med. 349:146-153.
37. Lee, A. Y. 2012. Treatment of established thrombotic events in patients with cancer. Thromb. Res. 129 (Suppl. 1):S146-S153.